Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) dropped its Q2 fiscal results for 2025, and while the revenue numbers shone bright—up 21% year-on-year to $5,391,339—the loss from operations took the shine off this growth. The company reported an operating loss of $1,677,480 for the quarter, up from $1,512,126 last year. Now that’s a head-scratcher considering the upbeat revenue claim.
Q2 Financials: Revenue Growth vs. Operational Losses
The figures show Jack Nathan's revenues over six months hit $10,670,548 compared to $8,795,598 in the previous year—a substantial leap. But hold on; why is it losing more money than ever? The stark reality is that clinic operations accounted for a whopping 89% of total revenues in Q2 but still couldn't pull the company into profitability.
- Revenue Highlights: $5.39 million in Q2 2025 vs. $4.57 million last year.
- Total Revenues for Six Months: Reached approximately $10.67 million versus nearly $8.8 million previously.
- Clinic Operations Contribution: Clinics pulled in about 90% of total revenue over six months—heavy reliance indeed.
This raises serious red flags regarding operational efficiency and expense management—especially when you see costs climb with expansion efforts across new clinics eating into profits like Pac-Man at an arcade.
The chairman said it best: "In Q2, we recorded a 21% increase in revenue," reflecting optimism amidst rising losses.
This blend of positive sales data paired with increasing operating losses indicates that growth isn't translating into financial health just yet; it's more like climbing a steep hill while dragging a boulder behind you!
